• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Outcomes and risk factors for failure of trabeculectomy in glaucomatous patients in Southwest China: a 325 eyes analysis.中国西南地区青光眼患者小梁切除术失败的结局及危险因素:325 眼分析
Int J Ophthalmol. 2023 Mar 18;16(3):367-374. doi: 10.18240/ijo.2023.03.06. eCollection 2023.
2
Success rates of 2-site phacoemulsification combined with fornix-based trabeculectomy using mitomycin C for primary angle-closure glaucoma and primary open-angle glaucoma in an Asian population.在亚洲人群中,两点式超声乳化联合丝裂霉素C穹窿部小梁切除术治疗原发性闭角型青光眼和原发性开角型青光眼的成功率。
Jpn J Ophthalmol. 2017 May;61(3):245-252. doi: 10.1007/s10384-017-0502-4. Epub 2017 Feb 10.
3
Deep sclerectomy-trabeculectomy with mitomycin C in treating glaucoma: postoperative long-term results.丝裂霉素C辅助的深层巩膜切除小梁切除术治疗青光眼:术后长期疗效
Int J Ophthalmol. 2022 Dec 18;15(12):1951-1959. doi: 10.18240/ijo.2022.12.09. eCollection 2022.
4
Bleb needling outcomes for failed trabeculectomy blebs in Asian eyes: a 2-year follow up.亚洲人眼中小梁切除术失败的滤过泡针刺结果:一项为期2年的随访研究
Int J Ophthalmol. 2015 Aug 18;8(4):748-53. doi: 10.3980/j.issn.2222-3959.2015.04.19. eCollection 2015.
5
Efficacy of Bevacizumab Compared to Mitomycin C Modulated Trabeculectomy in Primary Open Angle Glaucoma: A One-Year Prospective Randomized Controlled Study.贝伐单抗与丝裂霉素C辅助小梁切除术治疗原发性开角型青光眼的疗效比较:一项为期一年的前瞻性随机对照研究
Curr Eye Res. 2017 Feb;42(2):217-224. doi: 10.3109/02713683.2016.1164188. Epub 2016 Jun 7.
6
Trabeculectomy and Combined Phacoemulsification-Trabeculectomy: Outcomes and Risk Factors for Failure in Primary Angle Closure Glaucoma.小梁切除术及白内障超声乳化吸除联合小梁切除术:原发性闭角型青光眼的手术效果及失败危险因素
J Glaucoma. 2016 Sep;25(9):763-9. doi: 10.1097/IJG.0000000000000493.
7
Outcomes of primary trabeculectomy with mitomycin-C for primary angle closure glaucoma among supervised trainees in a tertiary eye center in Manila.在马尼拉的一家三级眼科中心,在监督培训生中,原发性闭角型青光眼行丝裂霉素 C 小梁切除术的结果。
Int Ophthalmol. 2021 May;41(5):1643-1650. doi: 10.1007/s10792-021-01705-4. Epub 2021 Jan 30.
8
Two-year outcome of repeat trabeculectomy with mitomycin C in primary open-angle and PEX glaucoma.原发性开角型青光眼和剥脱性青光眼再次小梁切除术联合丝裂霉素C的两年疗效
Eur J Ophthalmol. 2015 May-Jun;25(3):185-91. doi: 10.5301/ejo.5000542. Epub 2014 Dec 1.
9
Deep sclerectomy and trabeculectomy augmented with Mitomycin C: 2-year post-operative outcomes.深巩膜切除术联合丝裂霉素 C 增强的小梁切除术:2 年术后结果。
Graefes Arch Clin Exp Ophthalmol. 2021 Jul;259(7):1965-1974. doi: 10.1007/s00417-021-05144-w. Epub 2021 Mar 8.
10
Comparing the Safety and Efficacy of Phacogoniosynechialysis With Phacotrabeculectomy in the Management of Refractory Acute Primary Closure Angle Glaucoma With Cataract: A Multicenter Randomized Trial.比较晶状体睫状体分离术与小梁切除术治疗难治性急性原发性闭角型青光眼合并白内障的安全性和有效性:一项多中心随机试验
J Glaucoma. 2021 Jul 1;30(7):552-558. doi: 10.1097/IJG.0000000000001868.

引用本文的文献

1
Efficacy of trabeculectomy combined with collagen implant and mitomycin C compared to with mitomycin C alone in glaucoma: a retrospective cohort study.小梁切除术联合胶原植入物与单独使用丝裂霉素C治疗青光眼的疗效比较:一项回顾性队列研究
Int J Ophthalmol. 2025 Jun 18;18(6):1032-1041. doi: 10.18240/ijo.2025.06.09. eCollection 2025.
2
Long-Term Surgical Outcome of Trabeculectomy with Mitomycin C: A Comparison Between Primary and Secondary Glaucoma in Thailand.丝裂霉素C辅助小梁切除术的长期手术效果:泰国原发性青光眼与继发性青光眼的比较
Clin Ophthalmol. 2025 Apr 17;19:1299-1311. doi: 10.2147/OPTH.S518659. eCollection 2025.
3
Posterior scleral application of a mitomycin C-soaked sponge during trabeculectomy.小梁切除术期间在巩膜后部应用丝裂霉素C浸泡海绵。
Int J Ophthalmol. 2023 Jul 18;16(7):1071-1077. doi: 10.18240/ijo.2023.07.11. eCollection 2023.

本文引用的文献

1
Outcomes and risk factors for failure after trabeculectomy in Taiwanese patients: medical chart reviews from 2006 to 2017.台湾患者小梁切除术后的预后及失败风险因素:2006年至2017年病历回顾
Br J Ophthalmol. 2022 Mar;106(3):362-367. doi: 10.1136/bjophthalmol-2020-317303. Epub 2020 Nov 23.
2
Prospective Randomized Trial Comparing Mitomycin C Combined with Ologen Implant versus Mitomycin C Alone as Adjuvants in Trabeculectomy.前瞻性随机对照试验比较丝裂霉素 C 联合 Ologen 植入物与单独丝裂霉素 C 作为小梁切除术辅助剂的效果。
Ophthalmol Glaucoma. 2018 Sep-Oct;1(2):88-98. doi: 10.1016/j.ogla.2018.07.003. Epub 2018 Jul 30.
3
Treatment Outcomes in the Primary Tube Versus Trabeculectomy Study after 3 Years of Follow-up.原发性小梁切除术与小梁切开术研究的 3 年随访治疗结果。
Ophthalmology. 2020 Mar;127(3):333-345. doi: 10.1016/j.ophtha.2019.10.002. Epub 2019 Oct 9.
4
Phacoemulsification Versus Phacotrabeculectomy in Primary Angle-closure Glaucoma With Cataract: Long-Term Clinical Outcomes.超声乳化白内障吸除术与白内障青光眼联合手术治疗原发性闭角型青光眼合并白内障:长期临床疗效观察。
J Glaucoma. 2020 Jan;29(1):15-23. doi: 10.1097/IJG.0000000000001397.
5
Effectiveness of trabeculectomy with mitomycin C for glaucomatous eyes with low intraocular pressure on treatment eye drops.丝裂霉素 C 小梁切除术治疗低眼压治疗眼滴注青光眼眼的疗效。
Acta Ophthalmol. 2020 Feb;98(1):e81-e87. doi: 10.1111/aos.14195. Epub 2019 Jul 25.
6
Glaucoma surgery preferences when the surgeon adopts the role of the patient.当外科医生扮演患者角色时的青光眼手术偏好。
Eye (Lond). 2019 Oct;33(10):1577-1583. doi: 10.1038/s41433-019-0452-9. Epub 2019 May 1.
7
The prognosis of trabeculectomy in primary angle-closure glaucoma patients.原发性闭角型青光眼患者小梁切除术的预后
Int J Ophthalmol. 2019 Jan 18;12(1):66-72. doi: 10.18240/ijo.2019.01.10. eCollection 2019.
8
Relationship between age and surgical success after trabeculectomy with adjunctive mitomycin C.年龄与小梁切除术后联合丝裂霉素 C 治疗手术成功率的关系。
Eye (Lond). 2018 Aug;32(8):1321-1328. doi: 10.1038/s41433-018-0071-x. Epub 2018 Mar 27.
9
Comparison of surgical outcome of trabeculectomy and phacotrabeculectomy in Chinese glaucoma patients.中国青光眼患者小梁切除术与晶状体切除小梁切除术手术效果的比较。
Int J Ophthalmol. 2017 Dec 18;10(12):1928-1930. doi: 10.18240/ijo.2017.12.23. eCollection 2017.
10
Practice Preferences for Glaucoma Surgery: A Survey of the American Glaucoma Society.青光眼手术的实践偏好:美国青光眼协会的一项调查
J Glaucoma. 2017 Aug;26(8):687-693. doi: 10.1097/IJG.0000000000000720.

中国西南地区青光眼患者小梁切除术失败的结局及危险因素:325 眼分析

Outcomes and risk factors for failure of trabeculectomy in glaucomatous patients in Southwest China: a 325 eyes analysis.

作者信息

Qin Zuo-Xin, Ying Xi, Han Qing, Wang Lu, Tan Lian, Xu Yu-Fei, You Qiu-Xiang, Wu Nan, Liu Yong

机构信息

Southwest Hospital/Southwest Eye Hospital, Third Military Medical University (Army Medical University), Chongqing 400038, China.

Key Lab of Visual Damage and Regeneration & Restoration of Chongqing, Chongqing 400038, China.

出版信息

Int J Ophthalmol. 2023 Mar 18;16(3):367-374. doi: 10.18240/ijo.2023.03.06. eCollection 2023.

DOI:10.18240/ijo.2023.03.06
PMID:36935796
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10009591/
Abstract

AIM

To evaluate the outcomes and elucidate the failure factors for trabeculectomy with mitomycin C (MMC) in Southwest Chinese patients.

METHODS

A retrospective correlational study was conducted on the glaucomatous patients who underwent initial trabeculectomy with MMC in Southwest Hospital and had been followed up for 1-3y. A complete success for surgery is defined as a postoperative intraocular pressure (IOP) >5 and ≤21 mm Hg and 20% reduction of IOP compared to preoperative, without IOP-lowering medications. A qualified success for surgery is defined as the abovementioned postoperative IOP with or without IOP-lowering medications. The primary outcomes were IOP, the number of IOP-lowering medications, and cumulative success rate. The secondary outcomes included best corrected visual acuity (BCVA), mean deviation (MD) of visual field, major complications, and risk factors for surgical failure.

RESULTS

A total of 325 eyes of 261 glaucomatous patients had been included in our study. Both the mean IOP and the number of IOP-lowering medications were significantly decreased from 32.9±12.0 to 16.4±5.7 mm Hg (<0.0001) and 3.0±0.9 to 0.9±1.0 (<0.0001), respectively, at the last visit. The cumulative complete success rate and qualified success rate were 77.8% and 92.0% at 1-year follow-up, and 47.2% and 77.7% at 3-year follow up. There were no significant differences in surgical outcomes between primary angle-closure glaucoma (PACG) and primary open angle glaucoma (POAG). In PACG patients, the success rates of trabeculectomy were comparable with those of phacotrabeculectomy. Hypertension (HR=1.904, =0.011), encapsulated bleb (HR=2.756, <0.001), and more preoperative topical medications (HR=2.475, =0.008) were risk factors for surgical failure.

CONCLUSION

The qualified success rate of trabeculectomy with MMC in glaucomatous patients in the cohort is 92.0% at 1-year, and 77.7% at 3-year follow up. Hypertension, encapsulated bleb, and more preoperative topical medications are associated with surgical failure.

摘要

目的

评估中国西南地区青光眼患者行丝裂霉素C(MMC)小梁切除术的效果并阐明失败因素。

方法

对在西南医院接受初次MMC小梁切除术并随访1 - 3年的青光眼患者进行回顾性相关性研究。手术完全成功定义为术后眼压(IOP)>5且≤21 mmHg,与术前相比眼压降低20%,且无需使用降眼压药物。手术合格成功定义为上述术后眼压情况,无论是否使用降眼压药物。主要观察指标为眼压、降眼压药物使用数量及累积成功率。次要观察指标包括最佳矫正视力(BCVA)、视野平均缺损(MD)、主要并发症及手术失败的危险因素。

结果

本研究共纳入261例青光眼患者的325只眼。末次随访时,平均眼压和降眼压药物使用数量分别从32.9±12.0显著降至16.4±5.7 mmHg(<0.0001)和从3.0±0.9降至0.9±1.0(<0.0001)。1年随访时累积完全成功率和合格成功率分别为77.8%和92.0%,3年随访时分别为47.2%和77.7%。原发性闭角型青光眼(PACG)和原发性开角型青光眼(POAG)的手术效果无显著差异。在PACG患者中,小梁切除术的成功率与晶状体小梁切除术相当。高血压(HR = 1.904,P = 0.011)、包裹性滤过泡(HR = 2.756,<0.001)及术前更多局部用药(HR = 2.475,P = 0.008)是手术失败的危险因素。

结论

该队列中青光眼患者行MMC小梁切除术的合格成功率1年时为92.0%,3年时为77.7%。高血压、包裹性滤过泡及术前更多局部用药与手术失败相关。